Brief: Silexion Therapeutics Reports Positive Preliminary Immunotherapy Findings For Sil204 In Kras-Driven Pancreatic Cancer
14/05/2026 14:30
May 14 (Reuters) - Silexion Therapeutics Corp SLXN.O: SILEXION THERAPEUTICS REPORTS POSITIVE PRELIMINARY IMMUNOTHERAPY FINDINGS FOR SIL204 IN KRAS-DRIVEN PANCREATIC CANCER Source text: ID:nGNX3JVTwt Further company coverage: SLXN.O ((Reuters.Briefs@thomsonreuters.com;))